Twist Bioscience Corporation TWST Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $110.72M+6.8% | $103.7M+4.7% | $99.01M+3.1% | $96.06M+3.5% | $92.79M+4.6% | ||
| $53.59M+7.8% | $49.73M+3.2% | $48.17M+7.6% | $44.76M-4.3% | $46.77M+1.9% | ||
| $57.12M+5.8% | $53.97M+6.2% | $50.84M-0.9% | $51.3M+11.4% | $46.03M+7.4% | ||
| 51.6%-0.5pp | 52%+0.7pp | 51.3%-2.1pp | 53.4%+3.8pp | 49.6%+1.3pp | ||
| $19.7M+15.0% | $17.13M+0.7% | $17.01M-5.7% | $18.05M-24.5% | $23.92M+12.2% | ||
| $76.09M+9.1% | $69.74M+9.4% | $63.76M+0.6% | $63.37M-0.5% | $63.67M+13.3% | ||
| $156.58M+14.6% | $136.6M+5.9% | $128.94M+2.2% | $126.18M-6.1% | $134.35M+8.9% | ||
| -$45.86M-39.4% | -$32.9M-9.9% | -$29.93M+0.6% | -$30.12M+27.5% | -$41.56M-20.0% | ||
| -41.4%-9.7pp | -31.7%-1.5pp | -30.2%+1.1pp | -31.4%+13.4pp | -44.8%-5.7pp | ||
| $1.71M-21.4% | $2.18M-17.4% | $2.63M-2.1% | $2.69M-4.0% | $2.8M-13.5% | ||
| $175K-62.8% | $471K— | —— | -$836K-112% | -$394K-324% | ||
| -$43.98M-45.4% | -$30.25M-12.5% | -$26.88M-231% | $20.58M+153% | -$39.15M-24.3% | ||
| $43K-83.0% | $253K-1.6% | $257K+34.6% | $191K+9.1% | $175K+80.4% | ||
| -$44.02M-44.3% | -$30.51M-12.4% | -$27.14M-233% | $20.39M+152% | -$39.33M-24.5% | ||
| -39.8%-10.3pp | -29.4%-2.0pp | -27.4%-48.6pp | 21.2%+63.6pp | -42.4%-6.8pp | ||
| -$0.71-42.0% | -$0.50-11.1% | -$0.45-236% | $0.33+150% | -$0.66-24.5% | ||
| -$0.71-42.0% | -$0.50-11.1% | -$0.45-232% | $0.34+152% | -$0.66-24.5% | ||
| 61.7M+1.0% | 61.1M+2.1% | 59.8M-2.2% | 61.2M+2.5% | 59.6M+0.8% | ||
| 61.7M+1.0% | 61.1M+2.1% | 59.8M-0.3% | 60M+0.6% | 59.6M+0.8% | ||
| -$44.09M-44.8% | -$30.45M-13.2% | -$26.9M-233% | $20.19M+151% | -$39.32M-24.0% | ||
| $7.21M— | —— | —— | —— | $0— | ||
| $17K-55.3% | $38K— | —— | -$177K-608% | -$25K+59.0% | ||
| -$85K-572% | $18K— | —— | -$25K-183% | $30K+145% | ||
| $175K-62.8% | $471K— | —— | -$836K-112% | -$394K-324% | ||
| -$45.86M-39.4% | -$32.9M-9.9% | -$29.93M+0.6% | -$30.12M+27.5% | -$41.56M-20.0% | ||
| -$39.45M-47.7% | -$26.71M-11.6% | -$23.93M+0.5% | -$24.06M+31.6% | -$35.16M-24.4% | ||
| -$39.45M-47.7% | -$26.71M-11.6% | -$23.93M+0.5% | -$24.06M+31.6% | -$35.16M-24.4% | ||
| -35.6%-9.9pp | -25.8%-1.6pp | -24.2%+0.9pp | -25%+12.8pp | -37.9%-6.0pp | ||
| -$45.86M-39.4% | -$32.9M-9.9% | -$29.93M+0.6% | -$30.12M+27.5% | -$41.56M-20.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Twist Bioscience Corporation's revenue?
- Twist Bioscience Corporation (TWST) generated $409.5M in revenue over the trailing twelve months, up 17.8% year over year.
- Is Twist Bioscience Corporation profitable?
- Twist Bioscience Corporation is not currently profitable: it reported a net loss of $81.3M over the trailing twelve months, a -19.8% net margin.
- What are Twist Bioscience Corporation's profit margins?
- Gross margin is 52.1% and operating margin is -33.9%, with a -19.8% net margin.
- What is Twist Bioscience Corporation's earnings per share?
- Twist Bioscience Corporation's diluted EPS over the trailing twelve months is $-1.33.
- Where does Twist Bioscience Corporation's income statement data come from?
- Every line is extracted from Twist Bioscience Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
